Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 3 14Phase 1 8Phase NA 4Phase 1/2 3Phase 2/3 2Phase 4 1

Status

Unknown 17Recruiting 16Completed 14Not yet recruiting 10Active not recruiting 6Terminated 3Suspended 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Drug Therapy × Clear all
NCT02806258 2025-12-29

Néo-APBI-01

University Hospital, Grenoble

Phase 1/2 Terminated
362 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00321698 2024-08-29

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

OHSU Knight Cancer Institute

Phase 1/2 Terminated
25 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

St. Joseph's Hospital and Medical Center, Phoenix

Phase 1/2 Terminated
14 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡